You are here

Article Text

Article menu
Download PDFPDF
Review
Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data

Abstract

Adverse effects of glucocorticoids have been abundantly reported. Published reports on low dose glucocorticoid treatment show that few of the commonly held beliefs about their incidence, prevalence, and impact are supported by clear scientific evidence. Safety data from recent randomised controlled clinical trials of low dose glucocorticoid treatment in RA suggest that adverse effects associated with this drug are modest, and often not statistically different from those of placebo.

  • BMD, bone mineral density
  • COBRA, combination treatment in early rheumatoid arthritis (trial)
  • GC, glucocorticoid(s)
  • GI, gastrointestinal
  • NSAIDs, non-steroidal anti-inflammatory drugs
  • RA, rheumatoid arthritis
  • SLE, systemic lupus erythematosus
  • glucocorticoids
  • rheumatoid arthritis
  • adverse effects

http://dx.doi.org/10.1136/ard.2005.038638

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.